Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Short-term Efficacy of Novel No-touch Combined Directional Perfusion Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma With Cirrhosis.

NCT04513119 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT04513119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04513119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Short-term Efficacy of Novel No-touch Combined Directional Perfusion Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma With Cirrhosis.
Lead sponsor
Southwest Hospital, China
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
August 31, 2022
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma stage i, radiofrequency ablation